vs
Side-by-side financial comparison of enCore Energy Corp. (EU) and OCULAR THERAPEUTIX, INC (OCUL). Click either name above to swap in a different company.
OCULAR THERAPEUTIX, INC is the larger business by last-quarter revenue ($13.3M vs $12.4M, roughly 1.1× enCore Energy Corp.). enCore Energy Corp. runs the higher net margin — -173.9% vs -488.0%, a 314.0% gap on every dollar of revenue. enCore Energy Corp. produced more free cash flow last quarter ($7.2M vs $-57.1M).
Devon Energy Corporation is an American company engaged in hydrocarbon exploration. It is organized in Delaware with operational headquarters in the 50-story Devon Energy Center in Oklahoma City, Oklahoma. Its operations are in the Delaware Basin, Eagle Ford Group, and the Rocky Mountains.
Ocular Therapeutix, Inc. is a biopharmaceutical firm specializing in developing and commercializing innovative ophthalmic therapies. Its products treat acute and chronic eye conditions including post-surgical pain, glaucoma, and dry eye, serving patients and ophthalmology providers primarily across the U.S. and select global markets.
EU vs OCUL — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $12.4M | $13.3M |
| Net Profit | $-21.5M | $-64.7M |
| Gross Margin | 37.9% | 88.0% |
| Operating Margin | -135.9% | -526.5% |
| Net Margin | -173.9% | -488.0% |
| Revenue YoY | — | -22.4% |
| Net Profit YoY | — | -33.6% |
| EPS (diluted) | $-0.11 | $-0.27 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $12.4M | $13.3M | ||
| Q3 25 | $8.9M | $14.5M | ||
| Q2 25 | $3.7M | $13.5M | ||
| Q1 25 | $18.2M | $10.7M | ||
| Q4 24 | — | $17.1M | ||
| Q3 24 | — | $15.4M | ||
| Q2 24 | — | $16.4M | ||
| Q1 24 | — | $14.8M |
| Q4 25 | $-21.5M | $-64.7M | ||
| Q3 25 | $-4.8M | $-69.4M | ||
| Q2 25 | $-6.3M | $-67.8M | ||
| Q1 25 | $-24.2M | $-64.1M | ||
| Q4 24 | — | $-48.4M | ||
| Q3 24 | — | $-36.5M | ||
| Q2 24 | — | $-43.8M | ||
| Q1 24 | — | $-64.8M |
| Q4 25 | 37.9% | 88.0% | ||
| Q3 25 | 43.8% | 87.8% | ||
| Q2 25 | 30.8% | 85.6% | ||
| Q1 25 | -0.1% | 88.2% | ||
| Q4 24 | — | 92.8% | ||
| Q3 24 | — | 89.9% | ||
| Q2 24 | — | 90.8% | ||
| Q1 24 | — | 91.0% |
| Q4 25 | -135.9% | -526.5% | ||
| Q3 25 | -158.2% | -472.3% | ||
| Q2 25 | -526.1% | -502.6% | ||
| Q1 25 | -85.7% | -597.5% | ||
| Q4 24 | — | -296.1% | ||
| Q3 24 | — | -298.2% | ||
| Q2 24 | — | -265.1% | ||
| Q1 24 | — | -214.0% |
| Q4 25 | -173.9% | -488.0% | ||
| Q3 25 | -53.7% | -477.3% | ||
| Q2 25 | -172.7% | -503.9% | ||
| Q1 25 | -132.9% | -598.7% | ||
| Q4 24 | — | -283.3% | ||
| Q3 24 | — | -236.6% | ||
| Q2 24 | — | -266.3% | ||
| Q1 24 | — | -438.9% |
| Q4 25 | $-0.11 | $-0.27 | ||
| Q3 25 | $-0.03 | $-0.38 | ||
| Q2 25 | $-0.03 | $-0.39 | ||
| Q1 25 | $-0.13 | $-0.38 | ||
| Q4 24 | — | $-0.25 | ||
| Q3 24 | — | $-0.22 | ||
| Q2 24 | — | $-0.26 | ||
| Q1 24 | — | $-0.49 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $52.4M | $737.1M |
| Total DebtLower is stronger | $110.0M | — |
| Stockholders' EquityBook value | $229.2M | $654.3M |
| Total Assets | $430.4M | $808.1M |
| Debt / EquityLower = less leverage | 0.48× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $52.4M | $737.1M | ||
| Q3 25 | $91.9M | $344.8M | ||
| Q2 25 | $26.9M | $391.1M | ||
| Q1 25 | $29.7M | $349.7M | ||
| Q4 24 | — | $392.1M | ||
| Q3 24 | — | $427.2M | ||
| Q2 24 | — | $459.7M | ||
| Q1 24 | — | $482.9M |
| Q4 25 | $110.0M | — | ||
| Q3 25 | $109.3M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $229.2M | $654.3M | ||
| Q3 25 | $248.6M | $258.2M | ||
| Q2 25 | $264.7M | $305.9M | ||
| Q1 25 | $267.9M | $265.9M | ||
| Q4 24 | — | $315.3M | ||
| Q3 24 | — | $352.0M | ||
| Q2 24 | — | $377.7M | ||
| Q1 24 | — | $408.0M |
| Q4 25 | $430.4M | $808.1M | ||
| Q3 25 | $441.9M | $410.9M | ||
| Q2 25 | $359.4M | $451.3M | ||
| Q1 25 | $362.6M | $405.9M | ||
| Q4 24 | — | $457.9M | ||
| Q3 24 | — | $490.4M | ||
| Q2 24 | — | $517.1M | ||
| Q1 24 | — | $538.9M |
| Q4 25 | 0.48× | — | ||
| Q3 25 | 0.44× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $12.9M | $-54.2M |
| Free Cash FlowOCF − Capex | $7.2M | $-57.1M |
| FCF MarginFCF / Revenue | 57.8% | -430.9% |
| Capex IntensityCapex / Revenue | 46.7% | 21.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-45.0M | $-216.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $12.9M | $-54.2M | ||
| Q3 25 | $-20.3M | $-50.7M | ||
| Q2 25 | $-9.9M | $-55.2M | ||
| Q1 25 | $-7.7M | $-44.7M | ||
| Q4 24 | — | $-39.4M | ||
| Q3 24 | — | $-36.6M | ||
| Q2 24 | — | $-24.8M | ||
| Q1 24 | — | $-33.9M |
| Q4 25 | $7.2M | $-57.1M | ||
| Q3 25 | $-26.3M | $-56.7M | ||
| Q2 25 | $-14.1M | $-56.5M | ||
| Q1 25 | $-11.7M | $-46.6M | ||
| Q4 24 | — | $-39.6M | ||
| Q3 24 | — | $-36.6M | ||
| Q2 24 | — | $-25.5M | ||
| Q1 24 | — | $-34.1M |
| Q4 25 | 57.8% | -430.9% | ||
| Q3 25 | -296.6% | -390.0% | ||
| Q2 25 | -385.2% | -419.7% | ||
| Q1 25 | -64.1% | -435.6% | ||
| Q4 24 | — | -232.0% | ||
| Q3 24 | — | -237.6% | ||
| Q2 24 | — | -155.4% | ||
| Q1 24 | — | -231.1% |
| Q4 25 | 46.7% | 21.4% | ||
| Q3 25 | 68.0% | 41.2% | ||
| Q2 25 | 115.1% | 9.3% | ||
| Q1 25 | 21.7% | 18.1% | ||
| Q4 24 | — | 1.2% | ||
| Q3 24 | — | 0.6% | ||
| Q2 24 | — | 4.5% | ||
| Q1 24 | — | 1.7% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
